After completing a PhD in immuno-oncology in 2001 at GIMAP (INSERM), Jean-Philippe Herbeuval was awarded a 5-year Fogarty Fellowship at the NIH (USA) in Dr. G. Shearer's lab to work on the antiviral response to HIV. His work earned him the Norman P. Salzman Award (NIH, FDA, CDC) and the NIH Cash Award in 2005. He was recruited as a CR1 researcher by the CNRS in 2001 at Necker Hospital (UMR8147), where he established a research group. In 2012, Jean-Philippe Herbeuval founded the interdisciplinary team CBMIT at the Saints-Pères Biomedical Faculty to develop interdisciplinary and translational projects integrating immunology, virology, chemistry, and in silico modeling. In 2019, he founded the start-up Ermium Therapeutics with the investment fund Kurma Partners and Domain Therapeutics. He was awarded the national i-Lab Innovation Prize (BPI, Ministry of Research), and named “Ambassadeur innovation du CNRS”.

Seminar topic: Control of type I interferon production by CXCR4 minor pocket agonists (MiPAs): from HIV sexual transmission to novel therapeutic strategies for interferonopathies